Certified by Founder Lodge
Ascend Gene & Cell Therapies
United Kingdom - London
START UP
1 Disclosed Funding Rounds $132,500,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Ascend we aim high.
Ascend was founded to address the need for quality manufacturing capacity for any gene and cell therapy developer. We offer starting material, process and formulatio
Date | Round | Raised | Participating Investors |
---|---|---|---|
May, 10 ,2023 | Series A | $132,500,000 |